BNP/PUT/ALCON AG/80/0.1/20.06.25 Share Price

Warrant

DE000PC39BF4

Market Closed - Boerse Frankfurt Warrants 07:51:14 03/06/2024 pm IST
0.73 EUR +2.82% Intraday chart for BNP/PUT/ALCON AG/80/0.1/20.06.25
Current month+2.82%
1 month-38.14%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
03/24/03 0.73 +2.82%
31/24/31 0.71 -1.39%
30/24/30 0.72 -1.37%
29/24/29 0.73 +7.35%
28/24/28 0.68 +6.25%

Real-time Boerse Frankfurt Warrants

Last update June 03, 2024 at 07:51 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying ALCON INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC39BF
ISINDE000PC39BF4
Date issued 31/01/2024
Strike 80 CHF
Maturity 20/06/2025 (382 Days)
Parity 10 : 1
Emission price 1.55
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.84
Lowest since issue 0.61
Spread 0.01
Spread %1.32%

Company Profile

Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Sector
-
More about the company

Ratings for Alcon Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Alcon Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
89.3 USD
Average target price
93.38 USD
Spread / Average Target
+4.57%
Consensus